Board Meetings for AARTIDRUGS
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| AARTIDRUGS | Aarti Drugs Limited | 26 Jul 2019 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2019 | |
| AARTIDRUGS | Aarti Drugs Limited | 15 May 2019 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2019 and dividend | |
| AARTIDRUGS | Aarti Drugs Limited | 15 Mar 2019 | Buyback | To consider buyback for equity shares. | |
| AARTIDRUGS | Aarti Drugs Limited | 11 Feb 2019 | Financial Results | To consider and approve the financial results for the period ended December 31, 2018 | |
| AARTIDRUGS | Aarti Drugs Limited | 02 Nov 2018 | Financial Results | To consider and approve the financial results for the period ended September 30, 2018 | |
| AARTIDRUGS | Aarti Drugs Limited | 13 Aug 2018 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 | |
| AARTIDRUGS | Aarti Drugs Limited | 16 May 2018 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2018 and dividend | |
| AARTIDRUGS | Aarti Drugs Limited | 13 Feb 2018 | Results | Inter-alia, to consider, approve and take on record Audited Financial Results and Accounts for the quarter and nine months ended December 31, 2017. | |
| AARTIDRUGS | Aarti Drugs Limited | 08 Jan 2018 | Buyback | To consider inter alia, proposal of buyback of the fully paid-up equity shares of the Company including matters related/incidental thereto. | |
| AARTIDRUGS | Aarti Drugs Limited | 13 Nov 2017 | Results | inter-alia, to consider, approve and take on record Audited Financial Results and Accounts for the quarter and half year ended 30th September, 2017 | |
| AARTIDRUGS | Aarti Drugs Limited | 18 Aug 2017 | Results | Inter-alia, to consider, approve and take on record Audited Financial Results for the quarter ended June 30, 2017. | |
| AARTIDRUGS | Aarti Drugs Limited | 23 May 2017 | Results/Dividend | AARTIDRUGS : 23-May-2017 : The Company had informed the Exchange regarding a meeting of the Board of Directors of the Company schedule to be held May 18, 2017, inter-alia, to consider, approve and take on record Audited Financial Results and Audited Financial Statements (Standalone and Consolidated) for the quarter and year ended on March 31, 2017. The Company has now informed the Exchange that the meeting of the Board of Directors has now been postponed to May 23, 2017, and will consider and recommend final dividend, if any. (Purpose Revised) | |
| AARTIDRUGS | Aarti Drugs Limited | 23 May 2017 | Board meeting Rescheduled | The Company had informed the Exchange regarding a meeting of the Board of Directors of the Company schedule to be held May 18, 2017, inter-alia, to consider, approve and take on record Audited Financial Results and Audited Financial Statements (Standalone and Consolidated) for the quarter and year ended on March 31, 2017. The Company has now informed the Exchange that the meeting of the Board of Directors has now been postponed to May 23, 2017 (Revised). | |
| AARTIDRUGS | Aarti Drugs Limited | 18 May 2017 | Results | inter-alia, to consider, approve and take on record Audited Financial Results and Audited Financial Statements (Standalone and Consolidated) for the quarter and year ended on March 31, 2017. | |
| AARTIDRUGS | Aarti Drugs Limited | 08 Feb 2017 | Results | inter-alia, to consider, approve and take on record Audited Financial Results and Accounts for the quarter and nine months ended December 31, 2016. Further, that in accordance with Code of Conduct for Prevention of Insider Trading framed by the Company pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the securities of the Company will be closed for all Designated Persons (as defined in the code) of the Company from February 01, 2017 to February 10, 2017 (both days inclusive). |